Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026

COMPASS Pathways Plc (CMPS) — LONDON & NEW YORK, September 16, 2026--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026 and will participate in a fireside chat at 1:00pm ET.

Source: Business Wire — read the full announcement there.

See our COMPASS Pathways company profile for background, links, and more COMPASS Pathways news.